Compare FBRX & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBRX | TRC |
|---|---|---|
| Founded | N/A | 1843 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 498.8M |
| IPO Year | 2017 | 1995 |
| Metric | FBRX | TRC |
|---|---|---|
| Price | $21.06 | $18.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 369.5K | 96.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $36,000.00 | ★ $37,830,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1,891.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.12 | $15.31 |
| 52 Week High | $35.80 | $21.31 |
| Indicator | FBRX | TRC |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 45.25 |
| Support Level | $16.58 | $18.13 |
| Resistance Level | $22.84 | $19.78 |
| Average True Range (ATR) | 1.40 | 0.48 |
| MACD | 0.77 | -0.01 |
| Stochastic Oscillator | 81.45 | 38.46 |
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Tejon Ranch Co is a diversified real estate development and agribusiness company. It has six reporting segments: Real Estate - Commercial/Industrial, Multifamily, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.